398 related articles for article (PubMed ID: 27936346)
1. Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.
Liu B; Park S; Thompson CD; Li X; Lee JC
Virulence; 2017 Aug; 8(6):859-874. PubMed ID: 27936346
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates.
Park S; Gerber S; Lee JC
Infect Immun; 2014 Dec; 82(12):5049-55. PubMed ID: 25245803
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.
Watts A; Ke D; Wang Q; Pillay A; Nicholson-Weller A; Lee JC
Infect Immun; 2005 Jun; 73(6):3502-11. PubMed ID: 15908379
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice.
Tuchscherr LP; Buzzola FR; Alvarez LP; Lee JC; Sordelli DO
Infect Immun; 2008 Dec; 76(12):5738-44. PubMed ID: 18809660
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats.
Lee JC; Park JS; Shepherd SE; Carey V; Fattom A
Infect Immun; 1997 Oct; 65(10):4146-51. PubMed ID: 9317020
[TBL] [Abstract][Full Text] [Related]
6. Capsule-negative Staphylococcus aureus induces chronic experimental mastitis in mice.
Tuchscherr LP; Buzzola FR; Alvarez LP; Caccuri RL; Lee JC; Sordelli DO
Infect Immun; 2005 Dec; 73(12):7932-7. PubMed ID: 16299284
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus aureus capsular polysaccharide types 5 and 8 reduce killing by bovine neutrophils in vitro.
Kampen AH; Tollersrud T; Lund A
Infect Immun; 2005 Mar; 73(3):1578-83. PubMed ID: 15731056
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS
Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567
[TBL] [Abstract][Full Text] [Related]
9. Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence.
Luong TT; Lee CY
Infect Immun; 2002 Jul; 70(7):3389-95. PubMed ID: 12065477
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.
Thakker M; Park JS; Carey V; Lee JC
Infect Immun; 1998 Nov; 66(11):5183-9. PubMed ID: 9784520
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of capsular polysaccharide (CP) types of Staphylococcus aureus isolated from bovine mastitic milk and protection of S. aureus infection in mice with CP vaccine.
Han HR; Pak S; Guidry A
J Vet Med Sci; 2000 Dec; 62(12):1331-3. PubMed ID: 11193354
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States.
Mohamed N; Timofeyeva Y; Jamrozy D; Rojas E; Hao L; Silmon de Monerri NC; Hawkins J; Singh G; Cai B; Liberator P; Sebastian S; Donald RGK; Scully IL; Jones CH; Creech CB; Thomsen I; Parkhill J; Peacock SJ; Jansen KU; Holden MTG; Anderson AS
PLoS One; 2019; 14(1):e0208356. PubMed ID: 30641545
[TBL] [Abstract][Full Text] [Related]
13. Natural antibodies in normal human serum inhibit Staphylococcus aureus capsular polysaccharide vaccine efficacy.
Skurnik D; Kropec A; Roux D; Theilacker C; Huebner J; Pier GB
Clin Infect Dis; 2012 Nov; 55(9):1188-97. PubMed ID: 22806596
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus capsule type 8 antibodies provide inconsistent efficacy in murine models of staphylococcal infection.
Cook J; Hepler R; Pancari G; Kuklin N; Fan H; Wang XM; Cope L; Tan C; Joyce J; Onishi J; Montgomery D; Anderson A; McNeely T
Hum Vaccin; 2009 Apr; 5(4):254-63. PubMed ID: 18787395
[TBL] [Abstract][Full Text] [Related]
15. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge.
Fattom AI; Sarwar J; Ortiz A; Naso R
Infect Immun; 1996 May; 64(5):1659-65. PubMed ID: 8613375
[TBL] [Abstract][Full Text] [Related]
16. SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies.
Begier E; Seiden DJ; Patton M; Zito E; Severs J; Cooper D; Eiden J; Gruber WC; Jansen KU; Anderson AS; Gurtman A
Vaccine; 2017 Feb; 35(8):1132-1139. PubMed ID: 28143674
[TBL] [Abstract][Full Text] [Related]
17. Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.
Lattar SM; Noto Llana M; Denoël P; Germain S; Buzzola FR; Lee JC; Sordelli DO
Infect Immun; 2014 Jan; 82(1):83-91. PubMed ID: 24126523
[TBL] [Abstract][Full Text] [Related]
18. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis.
Nilsson IM; Lee JC; Bremell T; Rydén C; Tarkowski A
Infect Immun; 1997 Oct; 65(10):4216-21. PubMed ID: 9317029
[TBL] [Abstract][Full Text] [Related]
19. Typing of Staphylococcus aureus isolated from bovine mastitis cases in Australia and India.
Gogoi-Tiwari J; Babra Waryah C; Sunagar R; Veeresh HB; Nuthanalakshmi V; Preethirani PL; Sharada R; Isloor S; Bhat A; Al-Salami H; Hegde NR; Mukkur TK
Aust Vet J; 2015 Aug; 93(8):278-82. PubMed ID: 26220320
[TBL] [Abstract][Full Text] [Related]
20. Preparation and preclinical evaluation of two novel Staphylococcus aureus capsular polysaccharide 5 and 8-fusion protein (Hla-MntC-SACOL0723) immunoconjugates.
Ahmadi K; Aslani MM; Pouladfar G; Faezi S; Kalani M; Pourmand MR; Ghaedi T; Havaei SA; Mahdavi M
IUBMB Life; 2020 Feb; 72(2):226-236. PubMed ID: 31573748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
